Food and Drug Administration’s blessing to fast-track its vision technology, called Blindsight, through the regulatory ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...

Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation ...

In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon Musk claims — without evidence — will ...

Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food ...

Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Lunchly, the Lunchables-style brand of snack kits launched by YouTubers Logan Paul, Olajide "KSI" Olatunji, and Jimmy "MrBeast" Donaldson last month, is reportedly already getting dinged with ...

(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...

When Max Hodak, CEO of Science and former president of Neuralink, first saw a video of ... Its Blockbuster Drug Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...